Evaluating myometrial and cervical invasion in women with endometrial cancer: comparing subjective assessment with objective measurement techniques

Size: px
Start display at page:

Download "Evaluating myometrial and cervical invasion in women with endometrial cancer: comparing subjective assessment with objective measurement techniques"

Transcription

1 Ultrasound Obstet Gynecol 2013; 42: Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: /uog Evaluating myometrial and cervical invasion in women with endometrial cancer: comparing subjective assessment with objective measurement techniques F. MASCILINI*, A. C. TESTA*, C. VAN HOLSBEKE, L. AMEYE, D. TIMMERMAN and E. EPSTEIN *Department of Oncology, Catholic University of the Sacred Heart, Rome, Italy; Department of Obstetrics and Gynecology, Catholic University, Leuven, Belgium; Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium; Department of Women s and Children s Health, Karolinska University Hospital, Stockholm, Sweden KEYWORDS: cervical invasion; endometrial cancer; measurement; myometrial invasion; ultrasound ABSTRACT Objective To compare the diagnostic accuracy of subjective ultrasound assessment with that of objective measurement techniques in the evaluation of myometrial and cervical invasion in women with endometrial cancer. Methods This was a prospective multicenter study including 144 women with endometrial cancer undergoing transvaginal ultrasound. Myometrial and cervical invasion was evaluated subjectively, as well as objectively measured in different ways: endometrial thickness, tumor/uterine anteroposterior (AP) diameter ratio, minimal tumor-free margin, minimal tumor-free margin/uterine AP diameter ratio, tumor volume (threedimensional (3D)), tumor/uterine volume (3D) ratio, and distance from outer cervical os to lower margin of tumor (Dist-OCO). Histological assessment following hysterectomy was the gold standard. Results The sensitivity (72%) and specificity (76%) of tumor/uterine AP diameter (at cut-off, 0.53) were not significantly different from those of subjective evaluation (sensitivity, 77% (P = 0.44); specificity, 81% (P = 0.32)) for the prediction of deep myometrial invasion; all other objective measurement techniques had either a significantly lower sensitivity or a lower specificity. For all objective measurement techniques, except minimal tumor-free margin/uterine AP diameter ratio, fixing the sensitivity at the same level as that of subjective evaluation (i.e. 77%) gave a significantly lower specificity. Dist-OCO was the only parameter that might have potential to predict cervical invasion; it had a non-significantly higher sensitivity than did subjective evaluation (73% vs 54%, P = 0.06), but a significantly lower specificity (63% vs 93%, P < 0.001). Conclusion Subjective assessment of cervical and myometrial invasion is as good as or better than any objective measurement technique. The tumor/uterine AP diameter ratio and minimal tumor-free margin/uterine AP diameter ratio seem to be the best objective measurement techniques to predict deep myometrial invasion. It remains to be shown if objective measurements are useful to predict cervical invasion. Copyright 2013 ISUOG. Published by John Wiley & Sons Ltd. INTRODUCTION Endometrial carcinoma is the most frequent female pelvic malignancy and the seventh most common neoplasm worldwide, with the highest incidence in North America and Europe 1. Prognosis depends on the age of the patient, histological type and grade, tumor size, depth of myometrial invasion, and presence of cervical stromal invasion and lymph node metastases 2. Tumor size, myometrial invasion, and cervical stromal involvement cannot be determined by clinical examination. Preoperative knowledge of these parameters is advantageous in order to plan treatment; the clinical challenge is to select effectively for more radical surgery, with pelvic and paraaortic lymphadenectomy, those patients with a higher risk of relapse, while avoiding overtreatment in low-risk cases. Transvaginal ultrasound examination offers the possibility to evaluate the extent of myometrial infiltration and the presence of cervical stromal invasion 3.Thereis no consensus on how best to assess myometrial invasion by subjective evaluation or by objective measurements. Several studies have been published on the accuracy of subjective assessment in the prediction of deep myometrial invasion, with sensitivities of 68 93% and specificities of Correspondence to: Dr E. Epstein, Karolinska University Hospital, Stockholm, Sweden ( elisabeth.epstein@karolinska.se) Accepted: 11 April 2013 Copyright 2013 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER

2 354 Mascilini et al % 4 7. There are fewer publications on objective measurement techniques to assess myometrial invasion. In their study on 30 women with endometrial cancer, Karlsson and co-workers 8 suggested use of the tumor/uterine anteroposterior (AP) diameter ratio, a result of > 0.5 indicating high risk of deep myometrial invasion, with a sensitivity of 79% and a specificity of 100%. Alcazar et al. 6 suggested measuring the tumor-free margin using threedimensional (3D) virtual navigation, with a value < 9mm indicating a high risk of deep myometrial invasion; with this cut-off, they aimed to detect all women with deep myometrial invasion, i.e. with a sensitivity of 100%, and thus achieved a specificity of 61%. There are very few publications on the use of ultrasound to assess cervical invasion, but the results are generally very good for subjective assessment, with sensitivities ranging from 77 to 93% and specificities ranging from 85 to 99% 5,7,9. To the best of our knowledge, no objective measurement technique has been suggested to predict the presence of cervical invasion. The aim of this study was to compare subjective assessment and objective ultrasound measurements of cervical and myometrial invasion, using histology from hysterectomy specimens as the gold standard. A.C.T. in Rome and C.V.H. in Leuven/Genk). An examination protocol was filled out by the investigator directly after the examination. The protocol included assessment of the presence of deep ( 50%) myometrial invasion (yes/no) and cervical invasion (no invasion or stromal invasion suspected) and objective measurements (Figure 1) of: tumor extension/size; endometrial thickness; METHODS This study was a four-center collaboration between the ultrasound unit at the Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden, the Gynecologic Oncology Unit of the Catholic University of Sacred Heart, Rome, Italy, the Department of Obstetrics and Gynecology of Leuven University Hospital, Leuven, Belgium and the Department of Obstetrics and Gynecology of Ziekenhuis Oost-Limburg, Genk, Belgium. Approval was obtained from the ethics committee of Lund University (LU ) and from the local ethics committees of the Catholic University of Sacred Heart, Leuven University and Ziekenhuis Oost-Limburg. All women gave informed consent to participate. From January 2007 until May 2009, we included in the study consecutive women with histologically confirmed (by dilatation and curettage, hysteroscopy or simple endometrial biopsy) endometrial cancer, planned for surgery (which comprised total abdominal or robotic hysterectomy, both with bilateral salpingoophorectomy with systematic pelvic and para-aortic lymphadenectomy if appropriate, according to local protocols). All women underwent transvaginal ultrasound examination within 7 days prior to surgery. During the study period, none of the participating institutions routinely used other imaging techniques, such as magnetic resonance imaging (MRI), to assess the local extent of the tumor. We decided to use the FIGO (International Federation of Gynecology and Obstetrics) 2009 staging criteria 10 post hoc, based on the hysterectomy specimen, since the final analysis was made after all women had been included. All ultrasound examinations were performed by the principal investigators of each center (E.E. in Lund, Figure 1 Objective ultrasound measurements used in this study for the evaluation of myometrial invasion in women with endometrial cancer. (a) A, uterine anteroposterior (AP) diameter; B, tumor AP diameter; C, minimal tumor-free margin. B/A = tumor/uterine AP diameter ratio; C/A = minimal tumor-free margin/uterine AP diameter ratio. (b) D, tumor volume (three-dimensional (3D)). (c) E, uterine volume (3D). D/E = tumor/uterine volume (3D) ratio.

3 Subjective assessment vs objective measurement in endometrial cancer 355 tumor/uterine AP diameter ratio; minimal tumor-free margin; minimal tumor-free margin/uterine AP diameter ratio; tumor volume (3D); tumor/uterine volume (3D) ratio; and distance from outer cervical os to lower margin of tumor (Dist-OCO). In all women we collected still images of all measurements, videoclips and 3D volumes. Women were examined in the lithotomy position and had an empty bladder. The ultrasound equipment used in Lund was a GE Voluson E8 (GE Medical Systems, Zipf, Austria) ultrasound system, equipped with a RIC5-9 transducer, or a Philips IU22 (Philips Healthcare Systems, Bothell, WA, USA) ultrasound system equipped with a 3D9-3v transducer, and in the other two centers the GE Voluson E8, equipped with a RIC5-9 transducer, was employed. The uterus was scanned in the sagittal plane from cornu to cornu and in the (oblique) transverse plane from the cervix to the fundus. Having established an overview of the whole uterus, the image was magnified to contain only the uterine corpus. We defined the tumor mass in the sagittal plane, and measured the endometrial thickness and the tumor/uterine AP diameter ratio at the point at which we found the deepest myometrial invasion. In cases in which we did not suspect myometrial invasion, the tumor/uterine AP diameter ratio was calculated by measuring endometrial thickness and dividing it by the uterine AP diameter. The minimal tumor-free margin was measured in the plane in which we observed the smallest distance from the tumor to the serosa. In cases in which no obvious tumor was seen, Dist-OCO was measured from the lower border of the endometrial cavity to the outer cervical os. Tumor volume (3D) and tumor volume/uterine volume (3D) ratio were calculated from saved volumes using 4D View (GE Medical Systems), Virtual Organ Computer-aided AnaLysis (VOCAL) calculation or Philips QLAB quantification software using manual trace with 30 rotational steps. We included the whole endometrium in the 3D tumor volume measurements, since it is impossible to determine normal or cancer-affected endometrium based on the ultrasound image. The tumor margin was traced in the B-plane. In all centers a dedicated pathologist, with substantial experience in gynecological oncology, assessed the pathological specimens and completed a predetermined protocol. The histopathological variables assessed included histological type, grade and pathological stage (Stage IA, myometrial invasion < 50%; Stage IB, myometrial invasion > 50%; Stage II, cervical invasion; Stage III, spread beyond the uterus/cervix within the pelvis; Stage IV, spread beyond the pelvis. Only epithelial malignant tumors were included. Endometrioid and mucinous adenocarcinoma were classified into three grades (Grade 1, well differentiated; Grade 2, moderately differentiated; Grade 3, poorly differentiated). Serous cancer, clear cell cancer and carcinosarcoma were classified as Grade 3. Receiver operating characteristics (ROC) curves with 95% CIs were calculated for each ultrasound measurement as well as for subjective impression of cervical and myometrial invasion. It is, however, important to understand that a ROC curve based on subjective assessment is constructed from a one-point measurement, which will most probably underestimate the area under the curve (AUC), and this should be taken into consideration when interpreting the results. The optimal cut-off was defined as the point most distant from the diagonal line of discrimination. To compare the objective measurements to subjective evaluation we used McNemar s test and the method of DeLong was used for comparing AUCs. All calculations were performed using SPSS software (Statistical Package for Social Sciences (SPSS), version , SPSS Inc., Chicago IL, USA) and P < 0.05 was considered statistically significant. RESULTS A total of 144 consecutive women with endometrial cancer met the inclusion criteria and were enrolled prospectively. Lund contributed 56 patients, Leuven/Genk 46 and Rome 42. The patient demographics and tumor histological characteristics are presented in Table 1. The mean body mass index was 28.7 (SD ± 6.5), 36% used low-potency estrogens and 28% had a family history of gynecological and/or breast cancer. Approximately half of the women enrolled (49%, 71/144) were Stage IA and 68% (98/144) were Grade 1 or 2 (Table 1). The diagnostic accuracy of subjective assessment and of objective ultrasound measurement techniques in predicting deep myometrial involvement are summarized in Table 2. The AUC was not significantly different Table 1 Patient demographics and tumor histological characteristics in the study group of 144 women with endometrial cancer Characteristic Mean ± SD or n (%) Age (years) 65.8 (± 10.2) Body mass index (kg/m 2 ) 28.7 (± 6.5) Postmenopausal 132 (92) Family history of breast and/or gynecological 40 (28) cancer Current high-/medium-potency* hormone use 15 (10) Current low-potency estrogen use 52 (36) Current tamoxifen use 4 (3) FIGO stage IA 71 (49) IB 34 (24) II 12 (8) IIIA IIIC2 16 (11) IVA IVB 7 (5) Grade Endometrioid adenocarcinoma, Grade 1 56 (39) Endometrioid adenocarcinoma, Grade 2 42 (29) Endometrioid adenocarcinoma, Grade 3 22 (15) Non-endometrioid (serous adenocarcinoma/ 24 (17) clear cell adenocarcinoma/ carcinosarcoma) *Oral/dermal estradiol in combination with sequential or continuous progesterones. Oral/vaginal estriol or vaginal estradiol. In four women there were no remaining tumors at hysterectomy. FIGO, International Federation of Gynecology and Obstetrics (2009 staging criteria) 10.

4 356 Mascilini et al. Table 2 Comparison of diagnostic accuracy of subjective assessment with that of objective ultrasound measurement techniques in predicting deep myometrial involvement in women with endometrial cancer Cut-off AUC (95% CI) P* Sensitivity (% (n)) P Specificity (% (n)) P Subjective assessment 0.79 ( ) 77 (46/60) 81 (68/84) Objective measurement Minimal tumor-free margin/ ( ) (49/60) (61/84) uterine AP diameter ratio Tumor/uterine AP diameter ratio ( ) (43/60) (64/84) 0.32 Minimal tumor-free margin 7.1 mm 0.78 ( ) (51/60) (42/84) < Endometrial thickness 28.5 mm 0.74 ( ) (33/60) (71/84) 0.37 Tumor/uterine volume ratio (3D) ( ) (36/60) (71/84) 0.44 Tumor volume (3D) 9.9 ml 0.72 ( ) (41/60) (56/84) All comparisons were subjective assessment: *vs area under receiver operating characteristics curve (AUC) of objective assessment using DeLong s method; vs sensitivity of objective assessment using McNemar s test; vs specificity of objective assessment using McNemar s test. Table 3 Comparison of specificity of subjective assessment with that of objective ultrasound measurement techniques in predicting deep myometrial involvement in women with endometrial cancer, with sensitivity fixed at same level as that of subjective assessment Cut-off Sensitivity (% (n)) 95% CI (%) Specificity (% (n)) 95% CI (%) P Subjective assessment 77 (46/60) (68/84) Objective measurement Minimal tumor-free margin/ (46/60) (64/84) uterine AP diameter ratio Tumor/uterine AP diameter ratio (46/60) (48/84) < Minimal tumor-free margin 5.5 mm 75*(45/60) (61/84) Endometrial thickness 18.0 mm 75*(45/60) (50/84) < Tumor/uterine volume ratio (3D) *(45/60) (41/84) < Tumor volume (3D) 7.0 ml 77 (46/60) (48/84) < *Not possible to select 77% since too many patients had same value around cut-off point. Specificity of objective ultrasound measurement vs specificity of subjective assessment, at sensitivity fixed at that of subjective evaluation (77%), using McNemar s test. Table 4 Comparison of subjective assessment and objective measurement Dist-OCO (distance from outer cervical os to lower margin of tumor) for prediction of cervical invasion in women with endometrial cancer Cut-off AUC (95% CI) P* Sensitivity (% (n)) P Specificity (% (n)) P Subjective assessment 0.74 ( ) 54 (14/26) 93 (110/118) Dist-OCO 20.5 mm 0.75 ( ) (19/26) (74/118) < All comparisons were subjective assessment: *vs area under receiver operating characteristics curve (AUC) of objective assessment using DeLong s method; vs sensitivity of objective assessment using McNemar s test; vs specificity of objective assessment using McNemar s test. between subjective evaluation and any of the objective measurement techniques, but subjective evaluation showed a significantly higher sensitivity when compared with endometrial thickness and tumor/uterine volume (3D) ratio. Moreover, the subjective evaluation showed a significantly higher specificity compared with minimal tumor-free margin/uterine AP diameter ratio, minimal tumor-free margin and tumor volume (3D). The sensitivity (72%) and specificity (76%) of tumor/uterine AP diameter ratio (at cut-off 0.53) were not significantly different (P = 0.44 and P = 0.32, respectively) from those of subjective evaluation. We also compared the specificity of the objective measurement techniques, fixing sensitivity at the same level as that of subjective assessment (77%), with that of subjective evaluation and found that only minimal tumorfree margin/uterine AP diameter ratio was not significantly different (Table 3). The best objective parameter for the prediction of cervical invasion was Dist-OCO. Other parameters related to endometrial thickness, tumor volume or minimal tumor-free margin were tested but found to be not useful. Table 4 illustrates the subjective assessment and objective measurement of Dist-OCO for the prediction of cervical invasion. Dist-OCO had a nonsignificantly higher sensitivity compared with subjective evaluation (73% vs 54%, P = 0.06), but a significantly lower specificity (63% vs 93%, P < 0.001). The AUC did not differ between these methods. DISCUSSION In this prospective multicenter study on women with endometrial cancer we found that subjective assessment of cervical and myometrial invasion is as good as or better than any objective measurement technique.

5 Subjective assessment vs objective measurement in endometrial cancer 357 The tumor/uterine AP diameter ratio and minimal tumor-free margin/uterine AP diameter ratio seem to be the best objective measurement techniques to predict deep myometrial invasion. 3D volume measurements did not improve the assessment. The best objective parameter to predict cervical invasion was Dist-OCO. Currently, there is no consensus on the use of imaging methods in the preoperative assessment of women with endometrial cancer. Several publications have shown that subjective ultrasound evaluation is a reliable method in the assessment of myometrial 4 7 and cervical 5,7,9 invasion. Nevertheless, ultrasound assessment of myometrial and cervical invasion has not gained widespread use. One reason might be the lack of standardized criteria for the assessment of myometrial and cervical invasion. Two previous studies have suggested the use of objective measurement techniques to assess myometrial invasion. Karlsson and coworkers suggested using the tumor/uterine AP diameter with a cut-off of We also found tumor/uterine AP diameter ratio to be one of the best objective measurement techniques, with a similar cut-off (0.53). Alcazar and coworkers proposed the use of a minimal margin of 9 mm measured from the 3D volume 6, choosing a cut-off point with the aim of detecting all women with deep myometrial invasion, and obtained a specificity of 60%. When we used a 9-mm cut-off for minimal tumor-free margin with our data, we obtained a sensitivity of 90%, but the specificity was only 36%. This discrepancy may have been caused by differences in our study populations, and it highlights the need for prospective validation of cut-off points and measurement techniques. It was reassuring to see that subjective evaluation performed best or as well as any objective measurement technique. Subjective evaluation takes more features into account in addition to size and proportion, including regularity of the endometrial myometrial border and vascular pattern 11,12. For example, in large exophytic tumors, the tumor proportion will be great but the endometrial myometrial border will be regular and the focal vessel pattern will indicate to the examiner that it is most probably a large polypoid lesion bulging into the cavity and stretching the surrounding myometrium, rather than deeply invading. The strength of this study is the multicenter, prospective design and the large size of our series. One limitation might be the lack of generalizability of the results as our data need to be validated in a new series of patients. Reproducibility is also a major issue when dealing with diagnostic tests. An ideal design would be to assess reproducibility for the different measurements as well as for subjective evaluation, for both ultrasound and histological assessment, between several examiners. We feel that such a comparison deserves a separate paper. However, previous studies have shown that the reproducibility of endometrial thickness measurements in the assessment of women with postmenopausal bleeding is very high 13,14, although performance is less reliable in the hands of inexperienced sonographers 14.Inasmall series, Merce and coworkers showed that endometrial tumor volume measurements, using 3D ultrasound, were highly reproducible 15. However, even though the volume calculation has been shown to be reproducible, it is difficult to avoid small inaccuracies in the C-plane if the tumor margins are traced from another plane (as shown in Figure 1b). Another limitation could be the crude analysis of deep myometrial invasion (as yes/no); it would also be interesting to determine if the pathologist and ultrasonographer actually defined the point of deepest infiltration at the same spot. Regarding the statistical analysis comparing the AUC for subjective assessment and objective measurements, one must understand the difficulties in comparing the AUC for subjective evaluation, which is based on only one point and thus has a triangular shape. This might lead to an underestimation as compared to the objective measurement techniques which consisted of several points. There are also limitations related to ultrasound as a technique. Many women with endometrial cancer are obese, which often causes the uterus to take an upright position. It is well-known that endometrial assessment is very difficult if the endometrium is at an angle of 0 relative to the probe. This can, however, sometimes be overcome by using the free hand to manipulate the uterus, by applying slight pressure on the abdomen. Still, in a minority of women the image quality is too poor for appropriate assessment. Another pitfall might be large tumors bulging down into the cervical canal, mimicking cervical invasion. These cases can often be ruled out by the use of a dynamic examination technique; by assessing the presence of a sliding movement of the tumor over the inner cervical os, it is possible to differentiate a tumor that is bulging/sliding down into the cervical canal from one that is truly invading. One can also look for vessels entering the tumor at the inner cervical os, indicating cervical stromal invasion. Assessment of cervical invasion has traditionally been done by cervical curettage. In a study comprising 1297 women undergoing preoperative cervical curettage, the accuracy for prediction of cervical invasion was only 51% 16. In a recent study comprising 338 women, comparing cervical curettage to MRI, the latter yielded a significantly higher specificity (79% vs 91%, P = 0.001) and accuracy (77% vs 84%, P = 0.005) than did cervical curettage, whereas the sensitivity was not significantly different (65% vs 59%) 17. Hysteroscopy has also been used to assess cervical invasion, one study showing that hysteroscopy might have a higher sensitivity compared with both ultrasound and MRI (93%, 53% and 67%, respectively) 18. In our study, the sensitivity of cervical curettage was 56% and the specificity 89% for the assessment of cervical invasion. Moreover, 10% of the specimens could not be assessed due to an insufficient sample. These data suggest that ultrasound is at least as good as and probably better than cervical curettage for the assessment of cervical stromal invasion. Still, one cannot

6 358 Mascilini et al. expect ultrasound to detect minimal stromal invasion that can only be seen using a microscope. In conclusion, we found that subjective assessment of myometrial and cervical invasion performs better than or as well as selected objective measurement techniques in women with endometrial cancer. Further studies are needed to investigate if subjective evaluation or objective measurement techniques have the highest reproducibility, and how well they perform in the hands of examiners from other institutions, in particular in the hands of examiners with more or less experience. The cut-offs suggested for the objective measurements in this paper must also be tested prospectively before they can be used in a clinical setting. ACKNOWLEDGMENTS The study was supported by grants from FoU Region Skane, Sweden and ALF (project ) Stockholms läns landsting, Karolinska University Hospital, Sweden. REFERENCES 1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year The global picture. EurJCancer2001; 37: S4 S Benedet JL, Bender H, Jones H, 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol 2011; 38: Weber G, Merz E, Bahlmann F, Mitze M, Weikel W, Knapstein PG. Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma. Ultrasound Obstet Gynecol 1995; 6: Akbayir O, Corbacioglu A, Numanoglu C, Guleroglu FY, Ulker V, Akyol A, Guraslan B, Odabasi E. Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma by transvaginal ultrasound. Gynecol Oncol 2011; 122: Alcazar JL, Galvan R, Albela S, Martinez S, Pahisa J, Jurado M, Lopez-Garcia G. Assessing myometrial infiltration by endometrial cancer: uterine virtual navigation with threedimensional US. Radiology 2009; 250: Savelli L, Ceccarini M, Ludovisi M, Fruscella E, De Iaco PA, Salizzoni E, Mabrouk M, Manfredi R, Testa AC, Ferrandina G. Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet Gynecol 2008; 31: Karlsson B, Norstrom A, Granberg S, Wikland M. The use of endovaginal ultrasound to diagnose invasion of endometrial carcinoma. Ultrasound Obstet Gynecol 1992; 2: Sawicki W, Spiewankiewicz B, Stelmachow J, Cendrowski K. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer. Eur J Gynaecol Oncol 2003; 24: Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: Leone FP, Timmerman D, Bourne T, Valentin L, Epstein E, Goldstein SR, Marret H, Parsons AK, Gull B, Istre O, Sepulveda W, Ferrazzi E, Van den Bosch T. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group. Ultrasound Obstet Gynecol 2010; 35: Epstein E, Van Holsbeke C, Mascilini F, Masback A, Kannisto P, Ameye L, Fischerova D, Zannoni G, Vellone V, Timmerman D, Testa AC. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size. Ultrasound Obstet Gynecol 2011; 38: Epstein E, Valentin L. Intraobserver and interobserver reproducibility of ultrasound measurements of endometrial thickness in postmenopausal women. Ultrasound Obstet Gynecol 2002; 20: Karlsson B, Granberg S, Ridell B, Wikland M. Endometrial thickness as measured by transvaginal sonography: interobserver variation. Ultrasound Obstet Gynecol 1994; 4: Merce LT, Alcazar JL, Engels V, Troyano J, Bau S, Bajo JM. Endometrial volume and vascularity measurements by transvaginal three-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: intraobserver reproducibility. Gynecol Oncol 2006; 100: Leminen A, Forss M, Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 1995; 74: Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen OO, Trovik J, Salvesen HB. Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecol Oncol 2012; 126: Cicinelli E, Marinaccio M, Barba B, Tinelli R, Colafiglio G, Pedote P, Rossi C, Pinto V. Reliability of diagnostic fluid hysteroscopy in the assessment of cervical invasion by endometrial carcinoma: a comparative study with transvaginal sonography and MRI. Gynecol Oncol 2008; 111:

Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size

Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size Ultrasound Obstet Gynecol 2011; 38: 586 593 Published online 30 August 2011 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.9038 Gray-scale and color Doppler ultrasound characteristics

More information

Development and external validation of new ultrasound-based mathematical models for preoperative prediction of high-risk endometrial cancer

Development and external validation of new ultrasound-based mathematical models for preoperative prediction of high-risk endometrial cancer Ultrasound Obstet Gynecol 2014; 43: 586 595 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.13216 Development and external validation of new ultrasound-based mathematical

More information

Pre-operative Evaluation and Implications

Pre-operative Evaluation and Implications Pre-operative Evaluation and Implications Michal Zikan Gynecologic Oncology Center Charles University in Prague, First Faculty of Medicine No recommendation for screening of EC (HNPCC annual biopsies starting

More information

Original paper Med Ultrason 2016, Vol. 18, no. 2,

Original paper Med Ultrason 2016, Vol. 18, no. 2, Original paper Med Ultrason 2016, Vol. 18, no. 2, 201-206 DOI: 10.11152/mu.2013.2066.182.ege The prediction of myometrial infiltration by three-dimensional ultrasonography in patients with endometrial

More information

Staging and Treatment Update for Gynecologic Malignancies

Staging and Treatment Update for Gynecologic Malignancies Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths

More information

K. PÁLSDÓTTIR*, D. FISCHEROVA, D. FRANCHI, A. TESTA, A. DI LEGGE and E. EPSTEIN* ABSTRACT

K. PÁLSDÓTTIR*, D. FISCHEROVA, D. FRANCHI, A. TESTA, A. DI LEGGE and E. EPSTEIN* ABSTRACT Ultrasound Obstet Gynecol 2015; 45: 470 475 Published online 1 March 2015 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.14643 Preoperative prediction of lymph node metastasis and deep

More information

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%

More information

What is endometrial cancer?

What is endometrial cancer? Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women

More information

Endometrial Cancer. Incidence. Types 3/25/2019

Endometrial Cancer. Incidence. Types 3/25/2019 Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy

More information

Current staging of endometrial carcinoma with MR imaging

Current staging of endometrial carcinoma with MR imaging Current staging of endometrial carcinoma with MR imaging Poster No.: C-1436 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Magalhaes, H. Donato, C. B. Marques, P. Gomes, F. Caseiro Alves; Coimbra/PT

More information

Summary CHAPTER 1. Introduction

Summary CHAPTER 1. Introduction Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which

More information

Transvaginal ultrasound assessment of myometrial and cervical stroma. invasion in women with endometrial cancer -interobserver reproducibility

Transvaginal ultrasound assessment of myometrial and cervical stroma. invasion in women with endometrial cancer -interobserver reproducibility Transvaginal ultrasound assessment of myometrial and cervical stroma invasion in women with endometrial cancer -interobserver reproducibility among ultrasound experts and gynaecologists. Linda SE Eriksson

More information

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs

More information

Cervical Cancer: 2018 FIGO Staging

Cervical Cancer: 2018 FIGO Staging Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford

More information

Two- and three-dimensional transvaginal ultrasound with power Doppler angiography and gel infusion sonography for diagnosis of endometrial malignancy

Two- and three-dimensional transvaginal ultrasound with power Doppler angiography and gel infusion sonography for diagnosis of endometrial malignancy Ultrasound Obstet Gynecol 2015; 45: 734 743 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.13421 Two- and three-dimensional transvaginal ultrasound with power Doppler

More information

S. JANTARASAENGARAM*, N. PRADITPHOL, T. TANSATHIT*, C. VIPUPINYO* and K. VAIROJANAVONG*

S. JANTARASAENGARAM*, N. PRADITPHOL, T. TANSATHIT*, C. VIPUPINYO* and K. VAIROJANAVONG* Ultrasound Obstet Gynecol 2014; 43: 569 574 Published online 13 April 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.13200 Three-dimensional ultrasound with volume contrast imaging

More information

Sonographic Detection of Cervical Carcinoma With Metastases

Sonographic Detection of Cervical Carcinoma With Metastases 634026JDMXXX10.1177/8756479316634026Journal of Diagnostic Medical SonographyChappell and Fisher research-article2016 Case Study Sonographic Detection of Cervical Carcinoma With Metastases Journal of Diagnostic

More information

Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding

Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding DOI 10.1007/s13224-014-0627-z ORIGINAL ARTICLE Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding Singh Pushpa Dwivedi Pooja Mendiratta Shweta

More information

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion 5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year

More information

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

More information

American Journal of Oral Medicine and Radiology

American Journal of Oral Medicine and Radiology American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr ULTRASONOGRAPHIC EVALUATION OF ADNEXAL MASSES Nageswar Rao* Professor,

More information

The new FIGO classification in endometrial carcinoma

The new FIGO classification in endometrial carcinoma The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO

More information

Management of Endometrial Hyperplasia

Management of Endometrial Hyperplasia Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New

More information

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging

The International Federation of Gynecology and Obstetrics (FIGO) updated the staging Continuing Education Column Revised FIGO Staging System Hee Sug Ryu, MD Department of Obstetrics and Gynecology, Ajou University School of Medicine E - mail : hsryu@ajou.ac.kr J Korean Med Assoc 2010;

More information

One of the commonest gynecological cancers,especially in white Americans.

One of the commonest gynecological cancers,especially in white Americans. Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in

More information

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis

More information

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT

More information

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas) CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging

More information

P. SLADKEVICIUS and L. VALENTIN ABSTRACT

P. SLADKEVICIUS and L. VALENTIN ABSTRACT Ultrasound Obstet Gynecol 2013; 41: 318 327 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.12289 Intra- and interobserver agreement when describing adnexal masses using

More information

JMSCR Vol 05 Issue 06 Page June 2017

JMSCR Vol 05 Issue 06 Page June 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and

More information

Original Article Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients with endometrial carcinoma

Original Article Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients with endometrial carcinoma Int J Clin Exp Med 2015;8(10):19501-19505 www.ijcem.com /ISSN:1940-5901/IJCEM0014877 Original Article Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients

More information

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

Adjuvant Therapies in Endometrial Cancer. Emma Hudson Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial

More information

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA 2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

SCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC

SCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC 2 0 1 6 SCBT.MR MRI of Uterine Malignancy Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC aschers@gunet.georgetown.edu MUST READS Sala E, et al. The added role of

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

receive adjuvant chemotherapy

receive adjuvant chemotherapy Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer

More information

ARRO Case: Early-stage Endometrial Cancer

ARRO Case: Early-stage Endometrial Cancer ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American

More information

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas) C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2

More information

Index. B Bilateral salpingo-oophorectomy (BSO), 69

Index. B Bilateral salpingo-oophorectomy (BSO), 69 A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell

More information

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on? MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion

More information

C. VASCONCELOS 1,A.FÉLIX 2 & T. M. CUNHA 3. Journal of Obstetrics and Gynaecology, January 2007; 27(1): Introduction

C. VASCONCELOS 1,A.FÉLIX 2 & T. M. CUNHA 3. Journal of Obstetrics and Gynaecology, January 2007; 27(1): Introduction Journal of Obstetrics and Gynaecology, January 2007; 27(1): 65 70 Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and

More information

M. J. KUDLA* and J. L. ALCÁZAR ABSTRACT

M. J. KUDLA* and J. L. ALCÁZAR ABSTRACT Ultrasound Obstet Gynecol 2010; 35: 602 608 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7601 Does sphere volume affect the performance of three-dimensional power

More information

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department

More information

A NEW QUANTITATIVE METHOD TO EVALUATE ADNEXAL TUMORS

A NEW QUANTITATIVE METHOD TO EVALUATE ADNEXAL TUMORS ORIGINAL ARTICLE A NEW QUANTITATIVE METHOD TO EVALUATE ADNEXAL TUMORS Chung-Yuan Lee, Ching-Cheng Tseng, Chen-Bin Wang, Yu-Hsiang Lin, Chun-Hung Chen, Ting-Hung Wun, Ying-Lun Sun, Chih-Jen Tseng* Department

More information

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke

More information

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial

More information

Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women

Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following

More information

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with

More information

ARROCase: Locally Advanced Endometrial Cancer

ARROCase: Locally Advanced Endometrial Cancer ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal

More information

Markers HE4 and CA125 to Predict

Markers HE4 and CA125 to Predict Original Article Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer Narges Zamani; M.D. 1, Mitra Modares Gilani;

More information

INTRAUTERINE DEVICE = IUD INTRAUTERINE DEVICE = IUD CONGENITAL DISORDERS Pyometra = pyometrea is a uterine infection, it is accumulation of purulent material in the uterine cavity. Ultrasound is usually

More information

UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS

UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine

More information

ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS

ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by Reliable Cancer Therapies (RCT) as a service to patients,

More information

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic

More information

Impact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma

Impact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of

More information

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.

More information

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas ORIGINAL STUDY Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas Sigmund Ytre-Hauge, MD,*Þ Jenny A. Husby, MD,*Þ Inger

More information

Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging

Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging Ultrasound Obstet Gynecol 2008; 31: 560 566 Published online 9 April 2008 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.5295 Preoperative local staging of endometrial cancer: transvaginal

More information

Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics

Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics Ultrasound Obstet Gynecol 2010; 35: 723 729 Published online 24 March 2010 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7633 Three-dimensional power Doppler angiography in endometrial

More information

Case Scenario 1. History

Case Scenario 1. History History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family

More information

Cervical cancer presentation

Cervical cancer presentation Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000

More information

STUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas

STUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas UCSF Helen Diller Family Comprehensive Cancer Center Disclosures I have no financial disclosures STUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas Lee-may Chen, MD Department of Obstetrics,

More information

Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor

Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor Ultrasound Obstet Gynecol 2012; 39: 581 586 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.10120 Preoperative diagnosis of metastatic ovarian cancer is related to origin

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

This protocol is intended to assist pathologists in providing

This protocol is intended to assist pathologists in providing Protocol for the Examination of Specimens From Patients With Carcinomas of the Endometrium A Basis for Checklists Steven G. Silverberg, MD, for the Members of the Cancer Committee, College of American

More information

Janjira Petsuksiri, M.D

Janjira Petsuksiri, M.D GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND

More information

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst Gynaecology Case Presentation Organ Imaging 2016 University of Toronto Sarah Johnson 39 year old female Clinical history: Assess right ovarian cyst Clinically diagnosed endometriosis Started fertility

More information

surgical staging g in early endometrial cancer

surgical staging g in early endometrial cancer Risk adapted d approach to surgical staging g in early endometrial cancer Leon Massuger University Medical Centre St Radboud Nijmegen, The Netherlands Doing nodes Yes Yes Yes No No No 1957---------------------------

More information

Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding

Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding Ultrasound Obstet Gynecol 29; 33: 344 348 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 1.12/uog.6256 Value of endometrial thickness measurement for diagnosing focal intrauterine

More information

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:

More information

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages

Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan Cancer of the

More information

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE Case: Adenosarcoma with heterologous elements and stromal overgrowth o TAH, BSO, omentectomy, staging biopsies of cul-de-sac, bladder

More information

Power Doppler properties of endometrial polyps and submucosal fibroids: a preliminary observational study in women with known intracavitary lesions

Power Doppler properties of endometrial polyps and submucosal fibroids: a preliminary observational study in women with known intracavitary lesions Ultrasound Obstet Gynecol 2010; 35: 233 237 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7470 Power Doppler properties of endometrial polyps and submucosal fibroids:

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

Endometrial line thickness in different conditions.

Endometrial line thickness in different conditions. Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens

More information

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology

More information

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact

Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most

More information

29 Cancer of the Uterine Corpus

29 Cancer of the Uterine Corpus 29 Cancer of the Uterine Corpus Robbert Soeters INTRODUCTION Malignancies affecting the uterine corpus are endometrial adenocarcinoma and uterine sarcomas. ENDOMETRIAL ADENOCARCINOMA Endometrial adenocarcinoma

More information

Three-dimensional power Doppler ultrasound for the study of cervical cancer and precancerous lesions

Three-dimensional power Doppler ultrasound for the study of cervical cancer and precancerous lesions Ultrasound Obstet Gynecol 2012; 40: 576 581 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.11134 Three-dimensional power Doppler ultrasound for the study of cervical

More information

Histopathological Findings of Cystic Endometrial Morphology Based on Ultrasonographic Imaging in Premenopausal Women

Histopathological Findings of Cystic Endometrial Morphology Based on Ultrasonographic Imaging in Premenopausal Women Experimental & Clinical Article Gynecology; and Gynecological Oncology Histopathological Findings of Cystic Endometrial Morphology Based on Ultrasonographic Imaging in Premenopausal Women Tugba KINAY 1,

More information

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April

More information

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma

More information

A randomised trial of non-selective versus selective adjuvant Therapy in high risk Apparent stage 1 Endometrial Cancer QA MANUAL

A randomised trial of non-selective versus selective adjuvant Therapy in high risk Apparent stage 1 Endometrial Cancer QA MANUAL A randomised trial of non-selective versus selective adjuvant Therapy in high risk Apparent stage 1 Endometrial Cancer QA MANUAL For Surgical Specimen Processing and Microscopy Central Pathology Quality

More information

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB MRI for cervical and endometrial cancers Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB RCR 06(1) RCR 06(1) Technique Pelvic multiphased-array coil Fasting? Buscopan? ABDOMEN!!! Cx:+/- HR

More information

NAACCR Webinar Series /7/17

NAACCR Webinar Series /7/17 COLLECTING CANCER DATA: UTERUS 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

PALM-COEIN: Your AUB Counseling Guide

PALM-COEIN: Your AUB Counseling Guide PALM-COEIN: Your AUB Counseling Guide 10 million+ Treat the cause, not the symptom In the U.S, more than 10 million women between the ages of 35 and 49 are affected by AUB 1 Diagnosis Cause Structural

More information

New FIGO Staging of Uterine malignancies with MR Imaging: Correlation with Surgical and Histopathologic Findings

New FIGO Staging of Uterine malignancies with MR Imaging: Correlation with Surgical and Histopathologic Findings New FIGO Staging of Uterine malignancies with MR Imaging: Correlation with Surgical and Histopathologic Findings Poster No.: C-1548 Congress: ECR 2011 Type: Educational Exhibit Authors: J. Takahama, A.

More information

Ovarian Lesion Benign vs Malignant?

Ovarian Lesion Benign vs Malignant? Ovarian Lesion Benign vs Malignant? Michele Keenan 1,2 Bernice Dunne 2 Mary Moran 1 Therese Herlihy 1 1. Radiography and Diagnostic Imaging, School of Medicine, University College Dublin, Ireland 2. Midland

More information

MRI in Cervix and Endometrial Cancer

MRI in Cervix and Endometrial Cancer 28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial

More information

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Gynecologic Malignancies. Kristen D Starbuck 4/20/18 Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial

More information

Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)

Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) ** VALID ON DATE OF PRINTING ONLY all guidelines available on the Strategic Clinical Network website : GMLSC SCN Date first published

More information

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy

More information

TOC NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence,

More information

Study (trial) ID Study type Source of funding/conflic ts of interest (1) Selman et al., 2008

Study (trial) ID Study type Source of funding/conflic ts of interest (1) Selman et al., 2008 Uitgangsvraag 5 Welk pre-operatief onderzoek geeft bij patiënten met endometriumcarcinoom de meest accurate informatie over endocervicale ingroei, myometrium invasie en/of metastasen op afstand? Study

More information

THE RISK OF HYSTEROSCOPY IN SERIOUS ENDOMETRIAL DISEASES. Mary Girlie Z. Veloso, MD FPOGS, DMAS, Obstetrics - Gynecology

THE RISK OF HYSTEROSCOPY IN SERIOUS ENDOMETRIAL DISEASES. Mary Girlie Z. Veloso, MD FPOGS, DMAS, Obstetrics - Gynecology THE RISK OF HYSTEROSCOPY IN SERIOUS ENDOMETRIAL DISEASES Mary Girlie Z. Veloso, MD FPOGS, DMAS, Obstetrics - Gynecology ABSTRACT Objective: The aim of this review article is to compare varied studies on

More information

Endometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.

Endometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology. Endometrial cancer Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology dr.mate.szabolcs@gmail.com Epidemiology Developing countries Cervical cancer is the most common gyn. malignant tumor

More information

Transvaginal ultrasonography and hysteroscopy in postmenopausal bleeding a prospective study

Transvaginal ultrasonography and hysteroscopy in postmenopausal bleeding a prospective study Acta Obstet Gynecol Scand 2001; 80: 856 862 Copyright C Acta Obstet Gynecol Scand 2001 Printed in Denmark All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE

More information

Citation for published version (APA): Timmermans, A. (2009). Postmenopausal bleeding : studies on the diagnostic work-up

Citation for published version (APA): Timmermans, A. (2009). Postmenopausal bleeding : studies on the diagnostic work-up UvA-DARE (Digital Academic Repository) Postmenopausal bleeding : studies on the diagnostic work-up Timmermans, A. Link to publication Citation for published version (APA): Timmermans, A. (2009). Postmenopausal

More information